β¨ Medicines Classification
2070
NEW ZEALAND GAZETTE, No. 91
22 JUNE 2009
Oseltamivir; except when sold by a registered pharmacist between the months of May to September inclusive for the treatment of seasonal influenza to a consumer 12 years of age or more presenting in a pharmacy with early symptoms of influenza; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Sulfamethoxazole; except when combined with trimethoprim in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Trimethoprim; except when combined with sulfamethoxazole in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Zanamivir; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Dated this 19th day of June 2009.
STEPHEN McKERNAN, Director-General of Health.
go5328
PUBLISHED BY THE
DEPARTMENT OF INTERNAL AFFAIRS
PRINTED BY SECURACOPY
ISSN 0111-5650
ISSN 1177-8415
Price $1.60 (inc. GST)
β¨ LLM interpretation of page content
π₯
Classification of Prescription Medicines under the Medicines Act 1981
(continued from previous page)
π₯ Health & Social Welfare19 June 2009
Medicines, Prescription, Classification, Oseltamivir, Sulfamethoxazole, Trimethoprim, Zanamivir, Influenza, Pandemic
- STEPHEN McKERNAN, Director-General of Health
NZ Gazette 2009, No 91